Hostname: page-component-848d4c4894-8kt4b Total loading time: 0 Render date: 2024-06-20T00:51:31.655Z Has data issue: false hasContentIssue false
  • English
  • Français

Ziprasidone vs olanzapine for cognitive function in schizophrenia

Published online by Cambridge University Press:  16 April 2020

P.D. Harvey ,
G. Simpson ,
R. Horne ,
P.J. Weiden ,
M. Bari  and
S.J. Romano
P.D. Harvey
Affiliation:
Mount Sinai School of Medicine, New York
G. Simpson
Affiliation:
LAC & USC Medical Center, Los Angeles
R. Horne
Affiliation:
Lake Mead Hospital, Las Vegas
P.J. Weiden
Affiliation:
SUNY Health Sciences Center, Brooklyn
M. Bari
Affiliation:
Synergy Clinical Research Center, Crula Vista
S.J. Romano
Affiliation:
Pfizer, Inc., New York, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 100s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.